Description
The test was developed by MiRXES in collaboration with the Singapore Gastric Cancer Consortium (SGCC), the Diagnostic Development (DxD) Hub of Singapore’s Agency for Science, Technology and Research (A*STAR), National University Hospital (NUH), and Tan Tock Seng Hospital (TTSH).
* CE IVD marked and approved for IVD use by Singapore’s Health Sciences Authority
Benefits
1 , et al. Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population.
2 https://www.singaporestandardseshop.sg/Product/SSPdtDetail/952ba6cf-6c1e-4712-9719-07bd5ece3f09